|
|
 |
|
Viewing report
|
|
|
|
Industry Dynamics: 2010 Guide to the Asia-Pacific Life Sciences Industry
Ovum, Sep 2010, Pages: 62
Introduction
Pharmaceutical companies are expanding into the Asia-Pacific region to increase their market share and reduce costs. The life sciences industry is difficult enough for technology vendors to enter, but add to it the complexity of emerging markets, and the process can be downright overwhelming. Ovum provides an introduction to the life sciences in APAC in order for vendors to penetrate the market.
Features and benefits
- Offers an overview of the pharmaceutical and biotechnology sectors in Australia, China, India, and Japan- Discusses key areas where there is greatest need for technology in the APAC life sciences industry- Provides go-to-market strategies to help vendors enter the APAC pharma and biotech markets and realize successful
Highlights
Before attempting to penetrate the APAC pharma market, it is important to understand the complexity of the global life sciences industry. Once vendors understand the industry as a whole, they will better comprehend the dynamics of the APAC markets and how the developed and emerging pharma industries fit into their customers' global strategies.The Asia-Pacific life sciences industry varies greatly, comprised of both developed and emerging markets. It is also home to small, emerging biotech companies with up to ten employees as well as Big Pharma with thousands of employees. As wide as the spectrum is for size and type of life sciences company, so is the need for IT solutions.The emerging markets have seen tremendous growth, and this trend will likely continue, but not without the help of key IT solutions. The APAC pharma and biotech sectors are much more open to the use of IT that their Western counterparts, but it is still important for technology vendors to understand where and how to best realize success.
Your key questions answered
- Understand the pharmaceutical and biotechnology product lifecycle and business processes- Identify emerging areas of concern for pharmaceutical and biotechnology companies, particularly in Australia, China, India and Japan- Gain insight into what solutions and services will appeal most to APAC life sciences companies
|
|
|
|
